


Yposkesi launches construction of its second commercial bioproduction site
Yposkesi’s bioproduction Boost project awarded €1.2M in French government funding

Advent France Biotechnology appoints Sidonie Fabre as CFO

Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate

Launch of OncoSTART consortium supporting oncology entrepreneurs

Oncology: Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532

AELIX Therapeutics appoints Dr Melanie Rolli as CEO

MATWIN highlights four innovative projects in the fight against cancer
